Assembly Biosciences ASMB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$38.55M+1.1% | -$38.96M+2.4% | -$39.92M+0.6% | ||
| $122K-5.4% | $129K0.0% | $129K-0.8% | $130K0.0% | $130K+0.8% | ||
| $5.08M+8.6% | $4.68M+17.9% | $3.97M+28.2% | $3.09M0.0% | $3.09M-0.9% | ||
| $451K-53.7% | $974K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $1.06M-48.1% | $2.05M+2,625% | -$81K+91.4% | -$937K-187% | $1.08M— | ||
| -$34.51M+4.4% | -$36.1M— | —— | —— | —— | ||
| —— | —— | -$55.74M+0.2% | -$55.85M+0.6% | -$56.19M-9.9% | ||
| $85K+28.8% | $66K— | —— | —— | —— | ||
| $272.95M+18.8% | $229.83M-11.3% | $259.18M+179% | $92.96M-12.8% | $106.63M+17.8% | ||
| $147.6M+26.8% | $116.43M-1.2% | $117.83M-12.3% | $134.33M-1.3% | $136.13M+4.2% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $3.95M+94.7% | ||
| $172.89M-1.0% | $174.67M-8.6% | $191.21M+892% | $19.27M-38.6% | $31.37M+6.5% | ||
| $7.71M-61.7% | $20.11M+440% | -$5.92M-223% | $4.8M+2.9% | $4.66M-74.8% | ||
| —— | $3K+33.3% | $2.25K+50.0% | $1.5K+100% | $750— | ||
| —— | —— | $1.47M— | —— | —— | ||
| -$807K-7.5% | -$751K+17.4% | -$909K+13.8% | -$1.06M+2.6% | -$1.08M+22.6% | ||
| —— | —— | —— | —— | —— | ||
| $1.06M-48.1% | $2.05M— | —— | —— | —— | ||
| $836K-1.8% | $851K-14.9% | $1M-12.4% | $1.14M-10.6% | $1.28M-9.9% | ||
| $147.6M+26.8% | $116.43M-1.2% | $117.83M-12.3% | $134.33M-1.3% | $136.13M+4.2% | ||
| —— | $0-100% | $2.42M-50.0% | $4.83M-33.3% | $7.25M-25.0% | ||
| —— | $5.51M+33.3% | $4.13M— | —— | —— | ||
| -$34.51M+4.4% | -$36.1M— | —— | —— | —— | ||
| —— | —— | -$55.78M+0.1% | -$55.85M+0.6% | -$56.21M-9.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Assembly Biosciences generate?
- Assembly Biosciences (ASMB) generated -$77.4M in operating cash flow over the trailing twelve months.
- What is Assembly Biosciences's free cash flow?
- After $85.0K of capital expenditures, Assembly Biosciences's free cash flow was -$77.5M over the trailing twelve months, down 51.5% year over year.
- Where does Assembly Biosciences's cash flow data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
